KLONAM

This brand name is authorized in Ecuador.

Active ingredients

The drug KLONAM contains a combination of these active pharmaceutical ingredients (APIs):

1	Imipemide UNII 71OTZ9ZE0A - IMIPENEM
	Imipenem is a semi-synthetic derivative of thienamycin, the parent compound produced by the filamentous bacterium Streptomyces cattleya. Imipenem exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in Gram-positive and Gram-negative bacteria through binding to penicillin-binding proteins (PBPs).
	Read more about Imipemide
2	Cilastatin UNII 5428WXZ74M - CILASTATIN SODIUM
	Read more about Cilastatin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DH51	Imipenem and enzyme inhibitor	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28782-03-09